Infinity Pharmaceuticals, Inc.
INFIQOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$9076
P/E Ratio—
52W High$0.0001
52W Low$0.00001
Infinity Pharmaceuticals, Inc. (INFIQ) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · INFIQ · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $2.59M | $1.86M | $1.72M | $3.05M |
| Cost of Revenue | $1.56M | $1.12M | $1.04M | $7.31M |
| Gross Profit | $1.03M | $0.74M | $0.68M | ($4.26M) |
| Gross Margin %(computed) | 39.72% | 39.72% | 39.67% | -139.69% |
| Operating Expenses | ||||
| R&D Expenses | $32.41M | $31.65M | $26.76M | $27.12M |
| G&A Expenses | $13.46M | $14.17M | $12.42M | $14.29M |
| Total Operating Expenses | $45.87M | $45.82M | $39.18M | $41.41M |
| Operating Income | ($44.84M) | ($45.08M) | ($38.50M) | ($45.66M) |
| Operating Margin %(computed) | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.18M | $0.18M | $2.44M | $2.56M |
| Income Before Tax | ($44.37M) | ($45.26M) | ($40.49M) | ($47.11M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | ($0.05M) |
| Net Income | ($44.37M) | ($45.26M) | ($40.49M) | ($47.06M) |
| Net Margin %(computed) | — | — | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-0.50 | $-0.53 | $-0.68 | $-0.83 |
| Wtd Avg Shares | 89.25M | 85.60M | 59.86M | 56.98M |
| EBITDA | ($43.73M) | ($44.60M) | ($37.56M) | ($44.33M) |
| EBITDA Margin %(computed) | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Infinity Pharmaceuticals, Inc. data
About Infinity Pharmaceuticals, Inc. (INFIQ) Income Statement
Infinity Pharmaceuticals, Inc. (INFIQ) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, INFIQ reported revenue of $0.00B, gross profit of $0.00B (gross margin 39.72%), and net income of ($0.04B) — a net profit margin of -1711.11%.
Frequently asked questions
INFIQ · 4 questionsInfinity Pharmaceuticals, Inc. (INFIQ) reported revenue of $0.00B for 2022, up 39.6% year-over-year.
INFIQ revenueINFIQ salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09